Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-18T05:30:28.925Z Has data issue: false hasContentIssue false
  • English
  • Français

The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension

Published online by Cambridge University Press:  20 January 2015

Adam T. James ,
John D. Corcoran ,
Patrick J. McNamara ,
Orla Franklin  and
Afif F. El-Khuffash
Adam T. James
Affiliation:
Department of Paediatrics, The Rotunda Hospital, Dublin, Ireland
John D. Corcoran
Affiliation:
Department of Paediatrics, The Rotunda Hospital, Dublin, Ireland
Patrick J. McNamara
Affiliation:
Department of Physiology and Experimental Medicine, Hospital for Sick Children, Toronto, Canada Department of Neonatology, The Hospital for Sick Children, Toronto, Canada
Orla Franklin
Affiliation:
Department of Cardiology, Our Lady’s Children’s Hospital Crumlin, Dublin, Ireland
Afif F. El-Khuffash*
Affiliation:
Department of Paediatrics, The Rotunda Hospital, Dublin, Ireland Department of Paediatrics, Royal College of Surgeons in Ireland, Dublin, Ireland
*
Correspondence to: Dr A. El-Khuffash FRCPI, MD, DCE, Consultant Neonatologist, The Rotunda Hospital, Parnell Street, Dublin 1, Ireland. Tel: +353 1 873 0700; Fax: +353 1 872 6523; E-mail: afif@physicians.ie
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction

Milrinone may be an appropriate adjuvant therapy for infants with persistent pulmonary hypertension of the newborn. We aimed to describe the effect of milrinone administration on right and left ventricular function in infants with persistent pulmonary hypertension not responding to inhaled nitric oxide after 4 hours of administration.

Materials and methods

This is a retrospective review of infants born after or at 34 weeks of gestation with persistent pulmonary hypertension who received milrinone treatment. The primary endpoint was the effect of milrinone on myocardial performance and haemodynamics, including right and left ventricular outputs, tissue Doppler velocities, right ventricle and septal strain, and strain rate. Secondary endpoints examined included duration of inhaled nitric oxide and oxygen support.

Results

A total of 17 infants with a mean (standard deviation) gestation and birth weight of 39.8 (2.0) weeks and 3.45 (0.39) kilograms, respectively, were included in the study. The first echocardiogram was performed 15 hours after the commencement of nitric oxide inhalation. Milrinone treatment was started at a median time of 1 hour after the echocardiogram and was associated with an increase in left ventricular output (p=0.04), right ventricular output (p=0.004), right ventricle strain (p=0.01) and strain rate (p=0.002), and left ventricle s` (p<0.001) and a` (p=0.02) waves. There was a reduction in nitric oxide dose and oxygen requirement over the subsequent 72 hours (all p<0.05).

Conclusion

The use of milrinone as an adjunct to nitric oxide is worth further exploration, with preliminary evidence suggesting an improvement in both oxygenation and myocardial performance in this group of infants.

Keywords

Milrinonepulmonary hypertensionmyocardial functionneonatesstrain
Type
Original Articles
Information
Cardiology in the Young , Volume 26 , Issue 1 , January 2016 , pp. 90 - 99
Check for updates
Copyright
© Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Lipkin, PH, Davidson, D, Spivak, L, Straube, R, Rhines, J, Chang, CT. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr 2002; 140: 306–310.CrossRefGoogle ScholarPubMed
2. Walsh-Sukys, MC, Tyson, JE, Wright, LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000; 105: 14–20.CrossRefGoogle ScholarPubMed
3. Haworth, SG, Reid, L. Persistent fetal circulation: newly recognized structural features. J Pediatr 1976; 88: 614–620.CrossRefGoogle ScholarPubMed
4. Sehgal, A, Athikarisamy, SE, Adamopoulos, M. Global myocardial function is compromised in infants with pulmonary hypertension. Acta Paediatr 2012; 101: 410–413.CrossRefGoogle ScholarPubMed
5. Evans, N, Kluckow, M, Currie, A. Range of echocardiographic findings in term neonates with high oxygen requirements. Arch Dis Child Fetal Neonatal Ed 1998; 78: F105–F111.CrossRefGoogle ScholarPubMed
6. Peterson, AL, Deatsman, S, Frommelt, MA, Mussatto, K, Frommelt, PC. Correlation of echocardiographic markers and therapy in persistent pulmonary hypertension of the newborn. Pediatr Cardiol 2009; 30: 160–165.CrossRefGoogle ScholarPubMed
7. Musewe, NN, Poppe, D, Smallhorn, JF, et al. Doppler echocardiographic measurement of pulmonary artery pressure from ductal Doppler velocities in the newborn. J Am Coll Cardiol 1990; 15: 446–456.CrossRefGoogle ScholarPubMed
8. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997; 336: 597–604.CrossRefGoogle Scholar
9. Goldman, AP, Tasker, RC, Haworth, SG, Sigston, PE, Macrae, DJ. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1996; 98: 706–713.CrossRefGoogle ScholarPubMed
10. Silver, PJ, Harris, AL, Canniff, PC, et al. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle. J Cardiovasc Pharmacol 1989; 13: 530–540.CrossRefGoogle ScholarPubMed
11. LeJemtel, TH, Scortichini, D, Levitt, B, Sonnenblick, EH. Effects of phosphodiesterase inhibition on skeletal muscle vasculature. Am J Cardiol 1989; 63: 27A–30A.CrossRefGoogle ScholarPubMed
12. McNamara, PJ, Laique, F, Muang-In, S, Whyte, HE. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 2006; 21: 217–222.CrossRefGoogle ScholarPubMed
13. Bassler, D, Choong, K, McNamara, P, Kirpalani, H. Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 2006; 89: 1–5.CrossRefGoogle ScholarPubMed
14. McNamara, PJ, Shivananda, SP, Sahni, M, Freeman, D, Taddio, A. Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide. Pediatr Crit Care Med 2013; 14: 74–84.CrossRefGoogle ScholarPubMed
15. Poon, CY, Edwards, JM, Joshi, S, Kotecha, S, Fraser, AG. Optimization of myocardial deformation imaging in term and preterm infants. Eur J Echocardiogr 2011; 12: 247–254.Google ScholarPubMed
16. Joshi, S, Edwards, JM, Wilson, DG, Wong, JK, Kotecha, S, Fraser, AG. Reproducibility of myocardial velocity and deformation imaging in term and preterm infants. Eur J Echocardiogr 2010; 11: 44–50.CrossRefGoogle ScholarPubMed
17. Nestaas, E, Stoylen, A, Sandvik, L, Brunvand, L, Fugelseth, D. Feasibility and reliability of strain and strain rate measurement in neonates by optimizing the analysis parameters settings. Ultrasound Med Biol 2007; 33: 270–278.CrossRefGoogle ScholarPubMed
18. Mertens, L, Seri, I, Marek, J, et al. Targeted neonatal echocardiography in the neonatal intensive care unit: practice guidelines and recommendations for training writing group of the American Society of Echocardiography (ASE) in collaboration with the European Association of Echocardiography (EAE) and the Association for European Pediatric Cardiologists (AEPC). J Am Soc Echocardiogr 2011; 24: 1057–1078.CrossRefGoogle ScholarPubMed
19. Lopez, L, Colan, SD, Frommelt, PC, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the pediatric measurements writing group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 2010; 23: 465–495.CrossRefGoogle ScholarPubMed
20. James, A, Corcoran, D, Jain, A, et al. PC.40 assessment of myocardial performance using novel echocardiography markers in infants less than 29 weeks gestation during the transitional period. Arch Dis Child Fetal Neonatal Ed 2014; 99 (Suppl 1): A49–A50.CrossRefGoogle Scholar
21. Harada, K, Tamura, M, Toyono, M, Yasuoka, K. Comparison of the right ventricular tei index by tissue Doppler imaging to that obtained by pulsed Doppler in children without heart disease. Am J Cardiol 2002; 90: 566–569.CrossRefGoogle ScholarPubMed
22. Jaillard, S, Houfflin-Debarge, V, Riou, Y, et al. Effects of catecholamines on the pulmonary circulation in the ovine fetus. Am J Physiol Regul Integr Comp Physiol 2001; 281: R607–R614.CrossRefGoogle ScholarPubMed
23. Cheung, PY, Barrington, KJ. The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets. Crit Care 2001; 5: 158–166.CrossRefGoogle ScholarPubMed
24. Jain, A, Mohamed, A, EL-Khuffash, A, et al. A comprehensive echocardiographic protocol for assessing neonatal right ventricular dimensions and function in the transitional period: normative data and z-scores. J Am Soc Echocardiogr 2014; 27: 1293–1304.CrossRefGoogle ScholarPubMed
25. Hoffman, TM, Wernovsky, G, Atz, AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996–1002.CrossRefGoogle ScholarPubMed
26. Jain, A, Sahni, M, El-Khuffash, A, Khadawardi, E, Sehgal, A, McNamara, PJ. Use of targeted neonatal echocardiography to prevent postoperative cardiorespiratory instability after patent ductus arteriosus ligation. J Pediatr 2012; 160: 584–589.CrossRefGoogle ScholarPubMed
27. Deb, B, Bradford, K, Pearl, RG. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension. Crit Care Med 2000; 28: 795–799.CrossRefGoogle ScholarPubMed
28. Khazin, V, Kaufman, Y, Zabeeda, D, et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. J Cardiothorac Vasc Anesth 2004; 18: 156–159.CrossRefGoogle ScholarPubMed
29. Amoozgar, H, Tavakkoli, F, Ajami, GH, Borzoee, M, Basiratnia, M. Preload dependence of Doppler tissue imaging-derived indices in adolescents. Pediatr Nephrol 2008; 23: 1803–1808.CrossRefGoogle ScholarPubMed
30. El-Khuffash, AF, Jain, A, Weisz, D, Mertens, L, McNamara, PJ. Assessment and treatment of post patent ductus arteriosus ligation syndrome. J Pediatr 2014; 165: 46–52.CrossRefGoogle ScholarPubMed
31. El-Khuffash, AF, Jain, A, Dragulescu, A, McNamara, PJ, Mertens, L. Acute changes in myocardial systolic function in preterm infants undergoing patent ductus arteriosus ligation: a tissue Doppler and myocardial deformation study. J Am Soc Echocardiogr 2012; 25: 1058–1067.CrossRefGoogle ScholarPubMed
32. Bassler, D, Kreutzer, K, McNamara, P, Kirpalani, H. Milrinone for persistent pulmonary hypertension of the newborn. Cochrane Database Syst Rev 2010; (11): CD007802.Google ScholarPubMed